Name
AV Apteek OÜ
Registry code
14279299
VAT number
EE101995027
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.06.2017 (7)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
3 782 497 €
19 142 €
1%
-
-11 006 €
11
Submitted
No tax arrears
-174%
4%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Omanikukonto: JULIA FILEK 08.12.1990 (33) | 100% - 2 500.00 EUR | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
Anne Viidalepp 09.06.1966 (58) | - | - | - | Founder |
2019 08.07.2020 | 2020 30.06.2021 | 2021 03.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 650 731 € | 819 915 € | 996 292 € | 1 316 047 € | 3 782 497 € |
Net profit (loss) for the period | -11 401 € | -8 107 € | 13 699 € | 14 354 € | 19 142 € |
Profit Margin | -2% | -1% | 1% | 1% | 1% |
Current Assets | 100 970 € | 104 696 € | 108 658 € | 543 036 € | 535 420 € |
Fixed Assets | - | - | - | - | - |
Total Assets | 100 970 € | 104 696 € | 108 658 € | 543 036 € | 535 420 € |
Current Liabilities | 151 065 € | 162 897 € | 153 160 € | 573 184 € | 546 426 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | -50 095 € | -58 201 € | -44 502 € | -30 148 € | -11 006 € |
Employees | 4 | 3 | 5 | 5 | 11 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 1 058 851.15 € | 52 481.36 € | 42 469.7 € | 15 |
2023 Q4 | 1 045 349.38 € | 50 633.54 € | 40 437.7 € | 16 |
2023 Q3 | 921 537.35 € | 40 367.46 € | 36 427.39 € | 17 |
2023 Q2 | 1 012 818.12 € | 38 858.04 € | 32 750.26 € | 15 |
2023 Q1 | 961 377.68 € | 36 208.01 € | 29 489.51 € | 12 |
2022 Q4 | 332 956.3 € | 23 610.36 € | 18 635.69 € | 12 |
2022 Q3 | 261 070.69 € | 18 602.9 € | 15 830.9 € | 6 |
2022 Q2 | 290 867.82 € | 19 458.39 € | 15 695.76 € | 7 |
2022 Q1 | 318 295 € | 20 533.93 € | 14 855 € | 7 |
2021 Q4 | 303 044.17 € | 18 659.46 € | 13 882 € | 6 |
2021 Q3 | 227 422.34 € | 18 367.99 € | 14 983.36 € | 6 |
2021 Q2 | 280 796.16 € | 18 398.21 € | 14 940.42 € | 6 |
2021 Q1 | 243 328.87 € | 15 802.68 € | 12 572.46 € | 6 |
2020 Q4 | 246 077.08 € | 15 095.05 € | 11 687.3 € | 7 |
2020 Q3 | 175 314.33 € | 11 901.36 € | 11 307.31 € | 7 |
2020 Q2 | 246 084.28 € | 17 186.43 € | 12 710.73 € | 5 |
2020 Q1 | 217 049.85 € | 13 575.59 € | 10 319.93 € | 5 |